(Q40490612)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series: synthesis and biological behaviour (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Anne Vessieres

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Pascal Pigeon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Emmanuel Salomon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

Siden Top

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jacqueline Vaissermann

8

object named as

Jacqueline Vaissermann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

5

Michel Huché

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

Marie-Noëlle Rager

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

7

Claude Cabestaing

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1104-1113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

The lifetime risk of developing breast cancer

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Antiestrogens--tamoxifen, SERMs and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Advances in the science of estrogen receptor modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Molecular basis of agonism and antagonism in the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Structural insights into the mode of action of a pure antiestrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Estrogen receptor beta--a new dimension in estrogen mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Quantitation of estradiol receptors alpha and beta and progesterone receptors in human breast tumors by real-time reverse transcription-polymerase chain reaction. Correlation with protein assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

What pharmacologists can learn from recent advances in estrogen signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Prognostic significance of oestrogen receptor beta in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Oestrogen receptor beta in breast cancer: good, bad or still too early to tell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Labeling of Biomolecules for Medicinal Applications-Bioorganometallic Chemistry at Its Best The author thanks A. P. Schubiger and D. Grotjahn for reprints, and K. Severin for insightful discussions. The data in Figure 1 are used with the help and ki

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

New and efficient routes to biomolecules substituted with cyclopentadienyltricarbonylrhenium and -technetium derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Facile route to ferrocifen, 1-[4-(2-dimethylaminoethoxy)]-1-(phenyl-2-ferrocenyl-but-1-ene), first organometallic analogue of tamoxifen, by the McMurry reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Synthesis and evaluation of 11beta-substituted 21-chloro/iodo-(17alpha,20E/Z)-19-norpregna-1,3,5(10),20-te traene-3, 17beta-diols: high-affinity ligands for the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

Alternative mechanisms of action of anti-oestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400067

21 January 2018

Identifiers

DOI

10.1002/CBIC.200400067

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15300835%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference